SUPIME

This brand name is authorized in Nigeria.

Active ingredients

The drug SUPIME contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9548	Tablet	SUPIME 500 TABLET TAB 500 mg 1 X 10	152 CMS-PP-336589 SUPIME 500 TABLET CEFUROXIME AXETIL USP EQUIVALENT TO CEFUROXIME 500MG Cefuroxime Axetil USP equivalent to Cefuroxime 500mg, Lactose Monohydrate, Microcrystalline Crystalline Cellulose – 102, Croscarmellose sodium, Crospovidone, Sodium Lauryl Sulfate, Hydrogenated Castor Oil Powder form, Talc, Isopropyl Alcohol, Methylene Chloride. B4-9548 Drugs Imported Products 110 Prescription Only Medicine (POM) 6/6/2023 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India	06/07/2023
B4-9549	Powder for suspension	SUPIME POWDER FOR ORAL SUSPENSION 125MG/5ML PWD_F_SOL 125 mg/5 mL 100ML	153 CMS-PP-336592 SUPIME POWDER FOR ORAL SUSPENSION 125MG/5ML CEFUROXIME AXETIL USP EQV. TO CEFUROXIME 125MG/5ML Cefuroxime Axetil 125mg, Beta-Cyclodextrin, IPA, Purified Water, Sucrose, Xanthan Gum, Aspartame, Sodium Benzoate, Acesulfame – k, Talc, Citric Acid Anhydrous, Tutti Fruity Flavour, Colour Erythrosine Supra B4-9549 Drugs Imported Products 100ML Prescription Only Medicine (POM) 6/6/2023 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9548, B4-9549